Qube Research & Technologies (QRT)’s Corcept Therapeutics CORT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$16.5M Sell
225,382
-77,539
-26% -$5.69M 0.02% 707
2025
Q1
$34.6M Sell
302,921
-109,338
-27% -$12.5M 0.04% 387
2024
Q4
$20.8M Buy
412,259
+353,730
+604% +$17.8M 0.03% 526
2024
Q3
$2.71M Buy
+58,529
New +$2.71M ﹤0.01% 1314
2024
Q2
Sell
-143,747
Closed -$3.62M 3499
2024
Q1
$3.62M Buy
+143,747
New +$3.62M 0.01% 1204
2023
Q4
Sell
-2,009
Closed -$54.7K 3942
2023
Q3
$54.7K Sell
2,009
-103,442
-98% -$2.82M ﹤0.01% 2418
2023
Q2
$2.35M Buy
105,451
+75,650
+254% +$1.68M 0.01% 914
2023
Q1
$645K Sell
29,801
-106,963
-78% -$2.32M ﹤0.01% 1405
2022
Q4
$2.78M Buy
136,764
+59,881
+78% +$1.22M 0.01% 766
2022
Q3
$1.97M Buy
76,883
+45,079
+142% +$1.16M 0.01% 884
2022
Q2
$756K Sell
31,804
-8,762
-22% -$208K 0.01% 1204
2022
Q1
$914K Sell
40,566
-1,659
-4% -$37.4K 0.01% 1198
2021
Q4
$836K Buy
42,225
+12,560
+42% +$249K 0.01% 1297
2021
Q3
$584K Buy
+29,665
New +$584K 0.01% 1135
2021
Q2
Sell
-15,935
Closed -$379K 2332
2021
Q1
$379K Buy
+15,935
New +$379K 0.01% 1329
2020
Q3
Sell
-21,070
Closed -$354K 1731
2020
Q2
$354K Buy
21,070
+8,068
+62% +$136K 0.01% 1234
2020
Q1
$155K Buy
+13,002
New +$155K 0.01% 914